Chicago Business

Chicago Business

Vanqua Bio raises $45 million

Vanqua Bio raises million

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Wednesday, July 24, 2024

Vanqua Bio CEO Jim Sullivan and Fulton Labs at 1375 W. Fulton Market

Northwestern biotech spinout raises $45 million

Vanqua Bio is extending its runway and adding new investors as it develops drugs for Parkinson’s and Alzheimer’s diseases.

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>

VIEW OUR SUBSCRIPTION OFFERS

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

This email was sent

July 24, 2024 7:23pm
Country:

United States
Tags